Patent · US Active

Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase

US7943128B2 · kind B2 · utility

0Cited by

2References

30Claims

0Family size

Assignee

University Court of the University of St Andrews · GB

Inventors

Peter Coote · Waterlooville, GB
Shirley Graham · Ellicott City, US

Key dates

Filing date	Mar 29, 2007
Grant date	May 17, 2011
Priority date	—
Expiry date	Jan 13, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2300/45
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided an anti-microbial composition comprising a cationic peptide and a glycineglycine endopeptidase. The composition has been found to be synergistic against bacteria, especially Gram positive bacteria such as Staphylococcus aureus MSSA or MRSA. In one embodiment the composition comprises ranalexin, dermaseptin, magainin or mixtures thereof together with lysostaphin. The composition is useful for treating surfaces, including a wound surface in a patient or surfaces of an object (e.g. surgical instrument) or room.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.